178 related articles for article (PubMed ID: 25529435)
21. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy.
Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH
J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
23. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Pandey V; Gajbhiye KR; Soni V
Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
[TBL] [Abstract][Full Text] [Related]
24. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
[TBL] [Abstract][Full Text] [Related]
25. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.
Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789
[TBL] [Abstract][Full Text] [Related]
26. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z
J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578
[TBL] [Abstract][Full Text] [Related]
27. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
Vaidya B; Vyas SP
J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model.
Roy A; Singh MS; Upadhyay P; Bhaskar S
Int J Pharm; 2013 Mar; 445(1-2):171-80. PubMed ID: 23376226
[TBL] [Abstract][Full Text] [Related]
29. Acid-sensitive nanoparticles filled with tumor-destroying drugs promise new method to target and kill ovarian cancer cells.
Nanomedicine (Lond); 2006 Oct; 1(3):261-6. PubMed ID: 17716157
[No Abstract] [Full Text] [Related]
30. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages.
Park S; Kang S; Chen X; Kim EJ; Kim J; Kim N; Kim J; Jin MM
Biomaterials; 2013 Jan; 34(2):598-605. PubMed ID: 23099063
[TBL] [Abstract][Full Text] [Related]
32. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models.
Carvalho VFM; Migotto A; Giacone DV; de Lemos DP; Zanoni TB; Maria-Engler SS; Costa-Lotufo LV; Lopes LB
Eur J Pharm Sci; 2017 Nov; 109():131-143. PubMed ID: 28735040
[TBL] [Abstract][Full Text] [Related]
33. Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption.
Lee CS; Park W; Park SJ; Na K
Biomaterials; 2013 Dec; 34(36):9227-36. PubMed ID: 24008035
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
Lundberg BB
Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
[TBL] [Abstract][Full Text] [Related]
35. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
36. Denatured protein-coated docetaxel nanoparticles: Alterable drug state and cytosolic delivery.
Zhang L; Xiao Q; Wang Y; Zhang C; He W; Yin L
Int J Pharm; 2017 May; 523(1):1-14. PubMed ID: 28323094
[TBL] [Abstract][Full Text] [Related]
37. Folate-decorated thermoresponsive micelles based on star-shaped amphiphilic block copolymers for efficient intracellular release of anticancer drugs.
Rezaei SJ; Nabid MR; Niknejad H; Entezami AA
Int J Pharm; 2012 Nov; 437(1-2):70-9. PubMed ID: 22884832
[TBL] [Abstract][Full Text] [Related]
38. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
[TBL] [Abstract][Full Text] [Related]
39. Nanoformulation of paclitaxel to enhance cancer therapy.
Gu Q; Xing JZ; Huang M; Zhang X; Chen J
J Biomater Appl; 2013 Aug; 28(2):298-307. PubMed ID: 22561979
[TBL] [Abstract][Full Text] [Related]
40. CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.
Hu Q; Gao X; Kang T; Feng X; Jiang D; Tu Y; Song Q; Yao L; Jiang X; Chen H; Chen J
Biomaterials; 2013 Dec; 34(37):9496-508. PubMed ID: 24054848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]